Records containing: Solid Tumors
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2015-11-04Phase 1/2 Clinical Trial of the Combination of Trastuzumab (Herceptin) and Tanespimycin
-
CLINICAL_TRIALS study record update · 2015-11-02Open-label, Phase 1 Trial to Evaluate the Safety and Pharmacokinetic Parameters of a 2-day Pulse of Intravenous (IV) AC480 (AC480IV) Administered as Monotherapy and in Combination With Docetaxel in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2015-11-02Phase I, Multicenter, Open-label, Dose-escalating, Clinical and Pharmacokinetic Study of PM060184 Administered Intravenously to Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2015-11-02An Open-label, Comparative Study to Assess the Pharmacokinetics, Safety and Tolerability of Selumetinib (AZD6244, ARRY-142886) (Hyd-Sulfate) Following Single Oral Dosing to Healthy Subjects and to Subjects With Mild, Moderate, and Severe Hepatic Impairment
-
CLINICAL_TRIALS study record update · 2015-10-15An Open Label Treatment Extension Study of AMG 706
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2015-09-29A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2015-09-17An Open Label, Phase II Trial of BKM120 in Cancers With PIK3CA Activating Mutations
-
CLINICAL_TRIALS study record update · 2015-09-07A Phase I Study of MK2206 in Patients With Locally Advanced or Metastatic Solid Tumors
-
CLINICAL_TRIALS study record update · 2015-08-20Phase 1 Multiple Ascending Dose Study of XL184 Monotherapy in Japanese Subjects With Advanced or Metastatic Solid Tumors
-
CLINICAL_TRIALS study record update · 2015-08-19Pharmacokinetics Study of Nimotuzumab Single-dose and Multiple-dose in Combination With Irinotecan in Patients With Solid Tumors
-
CLINICAL_TRIALS study record update · 2015-08-13Monitoring of Plerixafor Off-Label Use in the European Group for Blood and Bone Marrow Transplantation (EBMT) Registry
-
CLINICAL_TRIALS study record update · 2015-07-28Safety of Nivestim® in Patients Treated With Neutropenia-inducing Anticancer Chemotherapy in Routine Practice
-
CLINICAL_TRIALS study record update · 2015-07-14A Phase Ib ,Single Center, Open-labeling, Multiple Oral Dose Study to Assess the Safety, Tolerability，PK and Efficacy Profile for Advanced Solid Tumor Patients in China
-
CLINICAL_TRIALS study record update · 2015-06-18Phase 1 Open Label Dose Escalation Study of the Safety and Pharmacokinetics of ME-344 as a Single Agent in Patients With Refractory Solid Tumors
-
CLINICAL_TRIALS study record update · 2015-06-16Phase I Trial of Intravenous Recombinant Human TNF-α and Liposomal Doxorubicin in Patients With Advanced Solid Tumors or Lymphomas
-
CLINICAL_TRIALS study record update · 2015-06-16A Phase 1 Study of REGN910 Administered Every 2 Weeks in Patients With Advanced Solid Malignancies
-
CLINICAL_TRIALS study record update · 2015-06-09A Phase II Clinical Trial Evaluating the Safety and Efficacy of Combination of Hyperthermia and Concurrent Chemoradiotherapy (CCRT) in Treatment Failure Solid Tumors
-
CLINICAL_TRIALS study record update · 2015-06-08A Phase 1 Study of LY2875358 in Japanese Patients With Advanced Malignancies
-
CLINICAL_TRIALS study record update · 2015-06-03Phase I Study of Erlotinib and Temsirolimus in Resistant Solid Malignancies
-
CLINICAL_TRIALS study record update · 2015-04-21Peritumoral Injection of Immature Dendritic Cels to Irradiated Metastases of Solid Tumors
-
CLINICAL_TRIALS study record update · 2015-04-20A Phase 1 Dose-Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of the Cyclin-Dependent Kinase (CDK) Inhibitor SCH 727965 Administered Weekly in Subjects With Advanced Malignancies
-
CLINICAL_TRIALS study record update · 2015-04-08A Phase 1 Open-label, Multiple Dose, Dose Escalation Study of Monoclonal Antibody AV-203 Administered in Subjects With Metastatic or Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2015-03-25A Phase I Study of Anti-CD3 x Cetuximab-Armed Activated T Cells, Low Dose IL-2, and GM-CSF for EGFR-Positive, Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2015-03-17A Phase 1b Study of Combined Angiogenesis Inhibition by Administering REGN910 and Aflibercept (Ziv-aflibercept) in Patients With Advanced Solid Malignancies
-
CLINICAL_TRIALS study record update · 2015-03-11A Phase I/Biomarker Study of Bevacizumab in Combination With CNTO 95 in Patients With Refractory Solid Tumors